KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Position in RPRX — Royalty Pharma plc
CIK 1021223
LOS ANGELES, CA
Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,775
+$4,720 QoQ
Shares Held
103
+368.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#595
of 641 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $15,557,323 across 9 Biotechnology names. RPRX ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,660 | $6,288,601 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,223 | $5,750,909 | |
| 3 | INCY |
Incyte Corp
|
24,992 | $2,833,093 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
2,371 | $675,663 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
103 | $5,775 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7 | $2,107 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
7 | $555 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
2 | $481 |
All Filings in RPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,775 | 103 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,055 | 22 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $850 | 22 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $776 | 22 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,080 | 141 | Shares | Sole | 2025-08-13 | |
| 2022-03-31 | $2,103 | 54 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||